Posted by Michael Wonder on 28 Jul 2016
EMA publishes EPAR for Zepatier (grazoprevir with elbasvir)
28 July 2016 - The EMA has published an EPAR for Merck's Zepatier.
The European Commission approved Zepatier on 22 July 2016 for the treatment of chronic hepatitis C in adults.
Zepatier will be subjected to additional monitoring by the EMA.
